Literature DB >> 17726744

Induction of experimental acute ulcerative colitis in rats by administration of dextran sulfate sodium at low concentration followed by intracolonic administration of 30% ethanol.

Yan Chen1, Jian-min Si, Wei-li Liu, Jian-ting Cai, Qin Du, Liang-jing Wang, Min Gao.   

Abstract

Several models of experimental ulcerative colitis have been reported previously. However, none of these models showed the optimum characteristics. Although dextran sulfate sodium-induced colitis results in inflammation resembling ulcerative colitis, an obvious obstacle is that dextran sulfate sodium is very expensive. The aim of this study was to develop an inexpensive model of colitis in rats. Sprague-Dawley rats were treated with 2% dextran sulfate sodium in drinking water for 3 d followed by an intracolonic administration of 30% ethanol. The administration of 2% dextran sulfate sodium followed by 30% ethanol induced significant weight loss, diarrhea and hematochezia in rats. Severe ulceration and inflammation of the distal part of rat colon were developed rapidly. Histological examination showed increased infiltration of polymorphonuclear leukocytes, lymphocytes and existence of cryptic abscesses and dysplasia. The model induced by dextran sulfate sodium at lower concentration followed by 30% ethanol is characterized by a clinical course, localization of the lesions and histopathological features similar to human ulcerative colitis and fulfills the criteria set out at the beginning of this study.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17726744      PMCID: PMC1963429          DOI: 10.1631/jzus.2007.B0632

Source DB:  PubMed          Journal:  J Zhejiang Univ Sci B        ISSN: 1673-1581            Impact factor:   3.066


  18 in total

Review 1.  An analysis of 10218 ulcerative colitis cases in China.

Authors:  Xue-Liang Jiang; Hui-Fei Cui
Journal:  World J Gastroenterol       Date:  2002-02       Impact factor: 5.742

Review 2.  Animal models of inflammatory bowel disease.

Authors:  Toshifumi Hibi; Haruhiko Ogata; Atsushi Sakuraba
Journal:  J Gastroenterol       Date:  2002       Impact factor: 7.527

3.  Hapten-induced model of chronic inflammation and ulceration in the rat colon.

Authors:  G P Morris; P L Beck; M S Herridge; W T Depew; M R Szewczuk; J L Wallace
Journal:  Gastroenterology       Date:  1989-03       Impact factor: 22.682

4.  A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice.

Authors:  I Okayasu; S Hatakeyama; M Yamada; T Ohkusa; Y Inagaki; R Nakaya
Journal:  Gastroenterology       Date:  1990-03       Impact factor: 22.682

5.  Characterisation of acute murine dextran sodium sulphate colitis: cytokine profile and dose dependency.

Authors:  B Egger; M Bajaj-Elliott; T T MacDonald; R Inglin; V E Eysselein; M W Büchler
Journal:  Digestion       Date:  2000       Impact factor: 3.216

6.  Colonic bacterial superantigens evoke an inflammatory response and exaggerate disease in mice recovering from colitis.

Authors:  Jun Lu; Arthur Wang; Sara Ansari; Robert M Hershberg; Derek M McKay
Journal:  Gastroenterology       Date:  2003-12       Impact factor: 22.682

Review 7.  Animal models of inflammatory bowel disease--an overview.

Authors:  W Strober
Journal:  Dig Dis Sci       Date:  1985-12       Impact factor: 3.199

8.  Mucin production and composition is altered in dextran sulfate sodium-induced colitis in rats.

Authors:  M Faure; D Moënnoz; F Montigon; C Mettraux; S Mercier; E J Schiffrin; C Obled; D Breuillé; J Boza
Journal:  Dig Dis Sci       Date:  2003-07       Impact factor: 3.199

Review 9.  Intestinal epithelial cell regulation of mucosal inflammation.

Authors:  Yimin Yu; Shanthi Sitaraman; Andrew T Gewirtz
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

10.  Dextran sulfate sodium-induced inflammation is enhanced by intestinal epithelial cell chemokine expression in mice.

Authors:  Yoshikazu Ohtsuka; Ian R Sanderson
Journal:  Pediatr Res       Date:  2003-01       Impact factor: 3.756

View more
  8 in total

1.  Sodium arsenite reduces severity of dextran sulfate sodium-induced ulcerative colitis in rats.

Authors:  Joshua J Malago; Hortensia Nondoli
Journal:  J Zhejiang Univ Sci B       Date:  2008-04       Impact factor: 3.066

2.  Dopaminergic signalling limits suppressive activity and gut homing of regulatory T cells upon intestinal inflammation.

Authors:  Valentina Ugalde; Francisco Contreras; Carolina Prado; Ornella Chovar; Alexandra Espinoza; Rodrigo Pacheco
Journal:  Mucosal Immunol       Date:  2020-11-12       Impact factor: 7.313

3.  Caffeic acid phenethyl ester is protective in experimental ulcerative colitis via reduction in levels of pro-inflammatory mediators and enhancement of epithelial barrier function.

Authors:  Mohammed N Khan; Majella E Lane; Paul A McCarron; Murtaza M Tambuwala
Journal:  Inflammopharmacology       Date:  2017-05-20       Impact factor: 4.473

4.  Therapeutic effect of curcumin on experimental colitis mediated by inhibiting CD8+CD11c+ cells.

Authors:  Hai-Mei Zhao; Fei Han; Rong Xu; Xiao-Ying Huang; Shao-Min Cheng; Min-Fang Huang; Hai-Yang Yue; Xin Wang; Yong Zou; Han-Lin Xu; Duan-Yong Liu
Journal:  World J Gastroenterol       Date:  2017-03-14       Impact factor: 5.742

5.  Albumin nano-encapsulation of caffeic acid phenethyl ester and piceatannol potentiated its ability to modulate HIF and NF-kB pathways and improves therapeutic outcome in experimental colitis.

Authors:  Murtaza M Tambuwala; Mohammed N Khan; Paul Thompson; Paul A McCarron
Journal:  Drug Deliv Transl Res       Date:  2019-02       Impact factor: 4.617

6.  Gardenia Jasminoides Ameliorates Antibiotic-Associated Aggravation of DNCB-Induced Atopic Dermatitis by Restoring the Intestinal Microbiome Profile.

Authors:  Hyo In Kim; Se Hyang Hong; Seo Yeon Lee; Jin Mo Ku; Min Jeong Kim; Seong-Gyu Ko
Journal:  Nutrients       Date:  2021-04-18       Impact factor: 5.717

7.  Anti-Inflammatory, Antioxidant, and Healing-Promoting Effects of Aloe vera Extract in the Experimental Colitis in Rats.

Authors:  Mahvash Alizade Naini; Asal Zargari-Samadnejad; Shayan Mehrvarz; Romina Tanideh; Mohammad Ghorbani; Amirreza Dehghanian; Maryam Hasanzarrini; Farnaz Banaee; Omid Koohi-Hosseinabadi; Nader Tanideh; Aida Iraji
Journal:  Evid Based Complement Alternat Med       Date:  2021-12-06       Impact factor: 2.629

8.  Aloperine Protects Mice against DSS-Induced Colitis by PP2A-Mediated PI3K/Akt/mTOR Signaling Suppression.

Authors:  Xiaoxia Fu; Fei Sun; Faxi Wang; Junai Zhang; Biying Zheng; Jixin Zhong; Tiantian Yue; Xuebao Zheng; Jun-Fa Xu; Cong-Yi Wang
Journal:  Mediators Inflamm       Date:  2017-09-19       Impact factor: 4.711

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.